**Core Concept:** Adult respiratory distress syndrome (ARDS) is a severe lung injury characterized by diffuse alveolar damage and capillary injury, leading to acute hypoxemia and pulmonary edema. The pathogenesis involves various cell types and inflammatory pathways.
**Why the Correct Answer is Right:** The correct answer, **D:** Neutrophils, play a crucial role in the pathogenesis of ARDS. In response to lung injury, neutrophils are recruited to the site of injury via various chemokines and cytokines, particularly interleukin-8 (IL-8). Once there, neutrophils release reactive oxygen species (ROS) and proteolytic enzymes, leading to direct alveolar-capillary damage. This results in further activation of the complement system, promoting the recruitment of other inflammatory cells, such as macrophages and lymphocytes, which contribute to the ongoing injury and inflammation.
**Why Each Wrong Option is Incorrect:**
A. **Macrophages:** Although macrophages are involved in the inflammatory response, they do not directly cause alveolar-capillary damage. Their main function is to engulf and clear debris and pathogens from the alveoli.
B. **Lymphocytes:** While lymphocytes are involved in the adaptive immune response, they do not directly cause alveolar-capillary damage. They primarily participate in the activation of other immune cells and the production of cytokines.
C. **Platelets:** Platelets are essential for hemostasis and wound healing, but they do not directly cause alveolar-capillary damage. Their role in ARDS is generally supportive, assisting in the clotting cascade and promoting inflammation.
**Clinical Pearl:** Understanding the role of different cell types in ARDS is crucial for guiding clinical management. Targeting neutrophils and inflammatory pathways has been explored in clinical trials, as inhibiting their activation may offer a therapeutic approach to reduce lung injury and improve patient outcomes.
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.